GINA recommendations in adults with symptomatic mild asthma and a smoking history

Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma

(2019) Richard Beasley et al.   NEW ENGLAND JOURNAL OF MEDICINE

GINA 2019: a fundamental change in asthma management

(2019) Helen K. Reddel et al.   EUROPEAN RESPIRATORY JOURNAL

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

(2019) Jo Hardy et al.   LANCET

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

(2018) Paul M. O’Byrne et al.   NEW ENGLAND JOURNAL OF MEDICINE

As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

(2018) Eric D. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Asthma and smoking-induced airway disease without spirometric COPD

(2017) Neil C. Thomson   EUROPEAN RESPIRATORY JOURNAL

Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control

(2015) Ver Bilano et al.   LANCET

Global asthma prevalence in adults: findings from the cross-sectional world health survey

(2012) Teresa To et al.   BMC PUBLIC HEALTH

Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study

(2011) Onno C.P. van Schayck et al.   RESPIRATORY MEDICINE